SBC Medical Group Holdings (SBC) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
28 May, 2026Executive summary
Annual meeting scheduled for July 9, 2026 (JST) / July 8, 2026 (ET), with virtual participation available.
Shareholders are encouraged to review proxy materials and vote by July 7, 2026.
Voting matters and shareholder proposals
Election of four directors: Yoshiyuki Aikawa, Yuya Yoshida, Ken Edahiro, and Fumitoshi Fujiwara.
Ratification of MaloneBailey, LLP as independent auditor for fiscal year ending December 31, 2026.
Proposal to amend the certificate of incorporation to eliminate plurality voting for directors.
Proposal to allow director removal without cause.
Proposal to opt out of Section 203 of Delaware General Corporation Law.
Proposal to provide for officer exculpation.
Proposal for other technical amendments to the certificate of incorporation.
Board of directors and corporate governance
Board recommends approval of all director nominees and proposed amendments.
Proposed governance changes aim to modernize director election and removal processes.
Latest events from SBC Medical Group Holdings
- Q2 2026 revenue rose 13% and net income surged 335%, fueled by AI and global expansion.SBC
Q2 2026 - All director nominees and charter amendments were approved at the virtual annual meeting.SBC
AGM 2026 - Underlying growth, AI-driven efficiency, and longevity-focused expansion drive future prospects.SBC
Sidoti Small-Cap Virtual Investor Conference - AI-driven, multi-brand healthcare model targets global expansion and double-digit growth.SBC
Emerging Growth Conference 93 - Largest aesthetic clinic network in Japan, expanding globally with high growth and profitability.SBC
Investor presentation - Scalable clinic network drives growth with data-driven efficiency and a focus on longevity.SBC
Noble Capital Markets June 2026 Emerging Growth Virtual Equity Conference - Shareholders will vote on director elections, auditor ratification, and major charter amendments.SBC
Proxy filing - Shareholders will vote on director elections, auditor ratification, and major charter amendments.SBC
Proxy filing - Strong financials, global expansion, and strategic initiatives drive growth and shareholder value.SBC
Life Sciences Investor Forum